Additionally, high expression of SRSF3 and DHCR24 was detected in other types of cancers, such as uterine corpus endometrial carcinoma and lung adenocarcinoma, suggesting that further investigations are required on the antitumor effects and underlying mechanisms of SFI003 in these cancers. Here, DHCR24 is linked to lung adenocarcinoma.